Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 130 for “"PLGA nanoparticles"”.
-
Development of versatile drug delivery strategies using PLGA nanoparticles
… to improve efficacy. Development of polymeric nanoparticles (NP) with slow drug-release kinetics coated with targeting ligands enables cell-specific sustained drug delivery, whilst minimising off-target side effects. In this thesis, a range of novel poly(lactic-co- glycolic acid) (PLGA) NP …
-
Axitinib Loaded PLGA nanoparticles for Age-Related Macular Degeneration
… Axitinib loaded poly (lactic-co-glycolic) acid (PLGA) nanoparticles. The nanoparticles were characterized for particle size and zeta potential as well as using DSC, TEM and in vitro drug release profile. The cytotoxicity of the formulation was evaluated on human retinal pigmented epithelium …
-
Wheat germ agglutinin-conjugated PLGA nanoparticles for the delivery of paclitaxel
Wheat germ agglutinin (WGA)-conjugated PLGA nanoparticles (NP) were prepared in this project to improve paclitaxel chemotherapy based on the preferential agglutination of WGA to malignant lung cells. Uptake of WGA-conjugated PLGA NP by A549 cells at 37A?C was 7.84-fold higher than control NP at …
-
The effect of PLGA nanoparticles on the osteogenic differentiation of hMSC
The polymer poly(lactic-co-glycolic acid) (PLGA) is both biocompatible and biodegradable and has therefore become one of the most frequently used polymers in the biomedical field. In this thesis, a literature study has been conducted on PLGA as a biomaterial. PLGA nanoparticles with a diameter of …
-
Consistent Fabrication of Ultrasmall PLGA Nanoparticles and their Potential Biomedical Applications
… the last few decades. Specifically, ultrasmall nanoparticles, ranging in size from 5 to 50 nm, are highly sought after for their physical and chemical properties and their ability to be easily transmitted though the bloodstream. By adjusting the material properties, size, surface potential, …
-
Development of irinotecan hydrochloride loaded PLGA nanoparticles for the treatment of glioblastoma
… is a major obstacle in the treatment of GBMs. Nanoparticles (NPs) are a promising strategy that can be designed to improve drug delivery to the brain. In this study, Irinotecan Hydrochloride (IRN)-loaded poly(lactide-co- glycolide) (PLGA) NPs and IRN and Pitavastatin (PTV) co-loaded PLGA NPs …
-
Pazopanib Loaded PLGA Nanoparticles for the Treatment of Age-related Macular Degeneration
… delivery method. In this study, pazopanib loaded PLGA‐NPs were prepared and the studied formulation had particle size of 132.1 ± 1.4 nm with PDI of 0.125 ±0.023 and 0.004± 0.13 mV for zeta potential. Entrapment efficiency was found 33.9 ± 2.5%. In vitro drug release study showed sustained drug …
-
Glass transition temperature of PLGA nanoparticles and the application in drug delivery
… of poly(D,L-lactic-co-glycolic acid) (PLGA) nanoparticles plays a crucial role in governing molecular mobility, diffusion, and consequently, drug release kinetics. However, the interaction among residual surfactant, drug effect, nanoscale confinement, and release medium on T<sub>g</sub> …
-
The effect of PLGA nanoparticles on the adipogenic commitment of human mesenchymal stem cells
Poly (Lactic-co-Glycolic) Acid (PLGA) is a widely used polymer that is approved to use in biomedical applications. Current studies try to incorporate the versatile nature of the polymer in the biomedical field as drug delivery vectors. This master’s thesis aimed at producing PLGA nanoparticles and …
-
DESIGN AND DEVELOPMENT OF CD205 TARGETED PLGA NANOPARTICLES AND EVALUATION OF ANTIGEN SPECIFIC IMMUNE RESPONSES
… to the release mechanism of the respective PLGA NP formulation. In addition, sufficient secretion of T helper cell 1 (Th1) and Th2 cytokines was observed. This confirmed the maturation of DCs as well as activation of the T cells. The T cell proliferation study confirmed the proliferation of …
-
INVESTIGATION OF LIGAND SIZE ON TARGETED PLGA NANOPARTICLES FOR HER2 BREAST CANCER: TRASTUZUMAB AND ITS ScFv ANTI-HER2 ANTIBODY
… breast cancer. Poly (D, L-lactide-co-glycolide) (PLGA) polymer, which is approved by FDA, was used to form nanoparticles (NPs) encapsulating docetaxel (DOC) as chemotherapy. HER2 antibody moieties, either whole IgG (TrAb) or single chain fragment variable (ScFv), were decorated on the PLGA NPs …
-
Delivery of Gemcitabine, Stearoyl Gemcitabine and Paclitaxel Through PLGA Nanoparticles and Its Effect on the Desmoplasia of Pancreatic Cancer Spheroids
… (P-gp) efflux receptors. Drug delivery using nanoparticles has been reported to help improve drug half-lives and bypass efflux receptors. This thesis aims to encapsulate PTX in PLGA nanoparticles (PTX-NP) and evaluate it along with GEM and stearoyl gemcitabine (St.GEM) in monolayer cell …
-
MODIFICATION OF THE SMALL INTESTINAL SUBMUCOSA USING PLGA NANOPARTICLES FOR ENHANCED TISSUE REGENERATION: FROM IN VITRO TO IN VIVO MODELS
… SIS biomaterial with poly(lactide-co-glycolide) nanoparticles (PLGA NPs) for better tissue regeneration.
-
Wheat germ agglutinin-conjugated poly-dl-lactic-co-glycolic acid (PLGA) nanoparticles for enhanced uptake and retention of paclitaxel by colon cancer cells
… the hypothesis that conjugation of WGA to PLGA nanoparticles loaded with paclitaxel (WNP) could improve the delivery of paclitaxel to colonic cancer cells. Glycosylation patterns of representative colon cancer cells (Caco-2 and HT-29 cells) and normal cells (colon fibroblasts, CCD-18Co …
-
Preparation and characterization of poly lactic-co-glycolic nanoparticles encapsulated with gentamicin for drug delivery applications
… have been dramatically improved. The ues of nanoparticles encapsulated with antibiotics to deliver drugs has been shown to be a potentially effective approach to control bacterial infections at a wound position. Recently, biodegradable and biocompatible polymers have drawn lots of attention …
-
Synthesis of Multifunctional Nanostructures for Controlled Release of Pharmaceuticals and Active Biomolecules
… Specifically, poly (lactic-co-glycolic acid) (PLGA) nanoparticles, chitosan nanoparticles, liposomal platforms, and hydrogels for the controlled and sustained release of drugs. PLGA nanoparticles were used to prepare dasatinib-loaded nanoparticles for controlled drug release. This was achieved …
-
PNIPAAM Immobilized Nanoparticles for Posterior Ocular Delivery
… design, synthesis, and characterization of the PLGA nanoparticles as a drug delivery vehicle to treat diseases associated with the posterior segment of the eye. The slow-release formulation was developed using PLGA nanoparticles and synthesized by the Double Emulsion Method (W1-O-W2). The PLGA …
-
Σύνθεση νανοφορέων για στοχευμένη μεταφορά αντιγόνων σε δενδριτικά κύτταρα
… for this purpose are poly(lactic-glycolic) acid (PLGA) nanoparticles, solid lipid nanoparticles with lipids in combinations of two (stearic-palmitic acid, stearic-lauric acid, palmitic-lauric acid), and poly(acrylic) acid-poly(allylamine) (PAA-PAH) complexes. The synthesis of PLGA nanoparticles is …
-
Selected radiotracers as imaging tools for the investigation of nano-sized delivery systems
… systems namely, poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles containing samarium-153 oxide ([153Sm]Sm2O3) as radiotracer and solid lipid nanoparticles (SLNs) containing technetium-99m-methylene diphosphonate (99mTc-MDP), after oral and intravenous administration to rats to prove that …
-
Multifunctional Nanoparticles for Cancer Therapy
… present study was to develop and characterize nanoparticles containing two anticancer agents having different mechanisms of action that would target both differentiated as well as cancer stem cells. The two hydrophobic antitumor agents (cyclopamine and paclitaxel) were entrapped in glyceryl …
Page 1 of 7